Global Laboratory Developed Tests Market Worth USD 22.30 Billion, Growing at a 6.9% CAGR from 2024 to 2032 - Report by Polaris Market Research (PMR)
22 mai 2024 09h10 HE
|
Polaris Market Research & Consulting LLP
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Global Laboratory Developed Tests Market was valued at USD 12.21 billion in 2023 and is anticipated to generate an estimated revenue...
Global Market for LDT Evolving, Shifting, and Growing (6.3% CAGR)
29 juin 2017 05h00 HE
|
BCC Research
Wellesley, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- The laboratory-developed test (LDT) market is evolving due to a variety of technological, financial and regulatory factors that will shift the...
Laboratory Heads from World-Renowned Academic Medical Centers Urge OMB Not to Release FDA Guidance on the Regulation of Laboratory-Developed Tests (LDTs)
16 juil. 2014 14h45 HE
|
ARUP Laboratories
SALT LAKE CITY, July 16, 2014 (GLOBE NEWSWIRE) -- Leading diagnostic innovators and laboratory directors from the nation's most respected nonprofit, academic medical centers have issued a letter...
Atossa Genetics to Conduct Free Webinar: How to Invest Ahead of Breast Cancer Awareness Month
23 sept. 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that Dr. Steven C. Quay, Chairman, President & CEO, will...
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
05 juin 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Peter J. Carbonaro has joined the Company as Senior Vice...
Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel
14 mai 2013 08h30 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak...